Dr. Mary Kinloch MD, FRCPC

Dr. Kinloch is a practicing gynecologic pathologist and signs out solid tissue molecular pathology. She has been in practice since 2015 with her career entirety at the University Saskatchewan.

Research interests for Dr. Kinloch include the molecular classification of endometrial cancer and quality improvement in molecular diagnostics including tissue stewardship of small cancer biopsies.

• Jamieson A, Huvila J, Thompson EF, Leung S, Chiu D, Lum A, McConechy M, Grondin K, Aguirre-Hernandez R, Salvador S, Kean S, Samouelian V, Gougeon F, Azordegan N, Lytwyn A, Parra-Herran C, Offman S, Gotlieb W, Irving J, Kinloch M, Helpman L, Scott SA, Vicus D, Plante M, Huntsman DG, Gilks CB, Talhouk A, McAlpine JN. Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification. Gynecol Oncol. 2022 May;165(2):201-214. doi: 10.1016/j.ygyno.2022.02.001. Epub 2022 Mar 1. PMID: 35246332.
• Baniak N, Gilks CB, DeCoteau J, Kinloch M. Diagnostic Variation in p53 Usage for Endometrial Carcinoma Diagnosis: Implications for Molecular Subtyping. Int J Gynecol Pathol. 2020 Nov;39(6):514-521. doi: 10.1097/PGP.0000000000000638. PMID: 31569187.
• Baniak N, Fadare O, Köbel M, DeCoteau J, Parkash V, Hecht JL, Hanley KZ, Gwin K, Zheng W, Quick CM, Jarboe EA, Liang SX, Kinloch M. Targeted Molecular and Immunohistochemical Analyses of Endometrial Clear Cell Carcinoma Show that POLE Mutations and DNA Mismatch Repair Protein Deficiencies Are Uncommon. Am J Surg Pathol. 2019 Apr;43(4):531-537. doi: 10.1097/PAS.0000000000001209. PMID: 30585826